Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.
Kamiya H, Komatsu S, Takashima Y, Ishida R, Arakawa H, Nishibeppu K, Kiuchi J, Imamura T, Ohashi T, Shimizu H, Arita T, Konishi H, Shiozaki A, Kubota T, Fujiwara H, Yagyu S, Iehara T, Otsuji E. Kamiya H, et al. Among authors: arita t. Br J Cancer. 2024 Mar;130(4):671-681. doi: 10.1038/s41416-023-02532-3. Epub 2023 Dec 26. Br J Cancer. 2024. PMID: 38148376
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer.
Kawaguchi T, Komatsu S, Ichikawa D, Morimura R, Tsujiura M, Konishi H, Takeshita H, Nagata H, Arita T, Hirajima S, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E. Kawaguchi T, et al. Among authors: arita t. Br J Cancer. 2013 Feb 5;108(2):361-9. doi: 10.1038/bjc.2012.546. Epub 2013 Jan 17. Br J Cancer. 2013. PMID: 23329235 Free PMC article.
Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma.
Komatsu S, Ichikawa D, Hirajima S, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Yagi N, Otsuji E. Komatsu S, et al. Among authors: arita t. Br J Cancer. 2014 Oct 14;111(8):1614-24. doi: 10.1038/bjc.2014.451. Epub 2014 Aug 12. Br J Cancer. 2014. PMID: 25117812 Free PMC article.
TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer.
Nishibeppu K, Komatsu S, Kiuchi J, Kishimoto T, Takashima Y, Shoda K, Arita T, Kosuga T, Konishi H, Shiozaki A, Kubota T, Okamoto K, Fujiwara H, Tsuda H, Otsuji E. Nishibeppu K, et al. Among authors: arita t. J Cancer. 2021 Jan 1;12(2):316-325. doi: 10.7150/jca.47577. eCollection 2021. J Cancer. 2021. PMID: 33391428 Free PMC article.
ANO9 regulates PD-L2 expression and binding ability to PD-1 in gastric cancer.
Katsurahara K, Shiozaki A, Kosuga T, Shimizu H, Kudou M, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E. Katsurahara K, et al. Among authors: arita t. Cancer Sci. 2021 Mar;112(3):1026-1037. doi: 10.1111/cas.14796. Epub 2021 Jan 22. Cancer Sci. 2021. PMID: 33404124 Free PMC article.
Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer.
Takashima Y, Komatsu S, Nishibeppu K, Kiuchi J, Ohashi T, Shimizu H, Arita T, Yamamoto Y, Konishi H, Morimura R, Shiozaki A, Kuriu Y, Ikoma H, Kubota T, Fujiwara H, Okamoto K, Otsuji E. Takashima Y, et al. Among authors: arita t. J Cancer. 2021 Aug 13;12(19):5960-5966. doi: 10.7150/jca.58154. eCollection 2021. J Cancer. 2021. PMID: 34476010 Free PMC article.
590 results